Table 3 of Eliseeva, Mol Vis 2021; 27:262-269.
Haplotype | Controls (n=396) | XFG patients (n=328) | POAG patients (n=208) | ||||||
---|---|---|---|---|---|---|---|---|---|
Frequency | OR | P | Pperm | Frequency | OR | P | Pperm | ||
CAA | 0.2163 | 0.1304 | 0.5 | 0.000099 | 0.001 | 0.1663 | 0.68 | 0.041 | 0.196 |
TAA | 0.0245 | 0.0091 | 0.34 | 0.093 | 0.502 | 0.0181 | 0.64 | 0.436 | 0.982 |
CGA | 0.0129 | 0.0118 | 1.92 | 0.321 | 0.942 | 0.009 | 2.11 | 0.891 | 1 |
CAG | 0.0129 | 0.0138 | 1.04 | 0.572 | 0.999 | 0.0123 | 1.56 | 0.508 | 0.991 |
TAG | 0.0143 | 0.0159 | 1.45 | 0.497 | 0.996 | 0.0152 | 1.84 | 0.308 | 0.916 |
CGG | 0.2227 | 0.1073 | 0.45 | 8.4E-06 | 0.001 | 0.0996 | 0.35 | 1.4E-06 | 0.001 |
TGG | 0.4963 | 0.6985 | 2.23 | 1.8E-09 | 0.001 | 0.6794 | 2.01 | 3E-07 | 0.001 |